共 10 条
[1]
Preclinical pharmacology of alendronate.[J].G. A. Rodan;J. G. Seedor;R. Balena.Osteoporosis International.1993, 3
[2]
Hyperstosis induced by the bisphosphanate (2-PEBP) in the oophoretomized rat.[J].Colin Movsowitz;Sol Epstein;Michael Fallon;Firhaad Ismail;Steven Thomas.Calcified Tissue International.1990, 3
[3]
Short- and long-term effects of a single dose of bisphosphonates on retinoid-induced bone resorption in thyroparathyroidectomized rats.[J].A. Stutzer;H. Fleisch;U. Trechsel.Calcified Tissue International.1988, 5
[4]
Preliminary observations of a form of coherence therapy for osteoporosis.[J].C. Anderson;R. D. T. Cape;R. G. Crilly;A. B. Hodsman;B. M. J. Wolfe.Calcified Tissue International.1984, 1
[5]
Inhibition by a new bisphosphonate (AHBuBP) of bone resorption induced by the MBT —2 tumor of mice..Nemoto R. Satou S. Miyagawa I. et al;.Cancer.1991,
[6]
Treatment of malignancy-associated hypercalcemia with YM175; a new bisphosphonate: elevated threshold for parathyroid hormone secretion in hypercalcemic patients..Fukumoto S. Matsumoto T. Takebe K. et al;.J Clin Endocrinol Metab.1994,
[7]
Effects of alendronate on bone mass in women with postmenopausal osteoporosis.Proceedings of Second International Symposium on Osteoporosis..Lombrdi A. Santora AC. Reid L. et al;.Beijing.1995,
[8]
Methylpentylaminopropylidenebisphosphonate (BM21.0955): a new potent and safe bisphosphonate for the treatment of cancer-associated hypercalcemia..Muster C. Schoter KH. Thiebaud D. et al;.Bone Miner.1993,
[9]
[10]

